Epigenetics Market 2018-2026 | Size, Share and Forecast | Credence Research

The global epigenetics market was valued at US$ 4.63 Bn in 2017, and is expected to reach US$ 16.50 Bn by 2026, expanding at a CAGR of 15.03 % from 2018 to 2026.

SANJOSE, United States - April 1, 2019 /MarketersMedia/ —

According to the latest market report published by Credence Research, Inc. "Epigenetics Market–Growth, Future Prospects and Competitive Analysis, 2016–2026," the global epigenetics market was valued at US$ 4.63 billion in 2017 and is expected to reach US$ 16.50 billion by 2026, expanding at a CAGR of 15.03 percent from 2018 to 2026.

Epigenetics is a relatively new science in the broader genetic field, involving the study of chemical modification of specific genes or gene-associated proteins. These epigenetic changes do not involve changes in the actual sequence of DNA. For the purpose of the study, the epigenetics market is segmented into product types such as kits (ChiP-Seq Kits, full-genome amplification kits, 5-HMC and 5-MC analysis kits and other epigenetics kits), reagents, enzymes (DNA-modifying enzymes, protein-modifying enzymes and RNA-modifying enzymes), instruments and bioinformatics tools. The demand for kits is currently the highest in the market and is expected to show the fastest growth in the market over the forecast period. Continuous advancement in the nature and accuracy of testing kits, increased prevalence of various diseases, wide availability of robust, user-friendly and cost-effective kits, and increasing application of epigenetic technologies in research laboratories are factors that catalyze overall market growth.

Browse the full report Epigenetics Market - Growth, Future Prospects and Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/epigenetics-market

The global epigenetics market is segmented on the basis of technologies such as DNA methylation, histone modification and other techniques. DNA methylation is the most widely accepted technology as it has great potential in the field of personalized drug development and understanding of functional mechanisms in complex cases of disease. Epigenetics is used in cancer, metabolic diseases, immune diseases, cardiovascular diseases and other areas. Cancer application held the largest market share in the 2017 base year, because epigenetic alterations are essential in the cell transformation to cancer, and their manipulation has great potential in cancer detection, prevention, and therapy.

North America is the current leader in the global epigenetics market and is expected to show dominance over the forecast period. Higher acceptance of new technologies, huge investment in R&D and developed healthcare infrastructure are key factors contributing to this region's dominance. On the other hand, Asia Pacific is projected to show the fastest market growth over the forecast period primarily due to increased healthcare spending and the development of healthcare infrastructure. Significant CRO activities in hubs like India also feature the rapid pace of the Asia Pacific market.

Market Competition Assessment:

The epigenetics market is highly competitive owing to the presence of market players across geographies with investments in research activities. The market currently is dominated by few key manufacturers such as Abcam, Plc., Active Motif, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Diagenode, Inc., Illumina, Inc., Merck & Co., Inc., New England Biolabs Inc., Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Zymo Research Corp. and others.

Request Sample (Free) @ https://www.credenceresearch.com/sample-request/59026

ToC:
Chapter 1. Preface
...............
Chapter 2. Executive Summary
...............
Chapter 3. Epigenetics: Market Dynamics and Outlook
...............
Chapter 4. Global Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Kits
4.2.1. ChiP-Seq Kits
4.2.2. Whole-Genome Amplification Kits
4.2.3. 5-HMC and 5-MC Analysis Kits
4.2.4. Other Epigenetics Kits
4.3. Reagents
4.4. Enzymes
4.4.1. DNA-Modifying Enzymes
4.4.2. Protein-Modifying Enzymes
4.4.3. RNA-Modifying Enzymes
4.5. Instruments
4.6. Bioinformatics Tools

Chapter 5. Global Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. DNA Methylation
5.3. Histone Modification
5.4. Other Techniques

Chapter 6. Global Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Cancer
6.3. Metabolic Diseases
6.4. Immune Diseases
6.5. Cardiovascular Diseases
6.6. Others

Chapter 7. Global Epigenetics Market, by Geography, 2016 – 2026 (US$ Mn)
................
Chapter 8. Company Profiles
8.1. Abcam, Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Type Portfolio
8.1.4. Key Developments
8.2. Active Motif, Inc.
8.3. Agilent Technologies, Inc.
8.4. Bio-Rad Laboratories, Inc.
8.5. Diagenode, Inc.
8.6. Illumina, Inc.
8.7. Merck & Co., Inc.
8.8. New England Biolabs, Inc.
8.9. Perkinelmer, Inc.
8.10. Qiagen N.V.
8.11. Thermo Fisher Scientific, Inc.
8.12. Zymo Research Corp.
..........................................toc continuous

Browse the full report Epigenetics Market - Growth, Future Prospects and Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/epigenetics-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/epigenetics-market-2018-2026-size-share-and-forecast-credence-research/497318

Source: MarketersMedia

Release ID: 497318